Stock SPRY ARS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
8.96 USD +1.47% Intraday chart for ARS Pharmaceuticals, Inc. +0.90% +63.50%
May. 09 ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 ARS Pharmaceuticals, Inc. Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's Chmp CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ARS PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+1.47%+0.90%+63.50%-1.43% - 865M
Neutral
Bullish
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. SPRY Stock
  4. Charts ARS Pharmaceuticals, Inc.
  5. Comparison Chart